The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
General Investing >> Money Manager Interviews >> December 30, 2014

Building a Sector-Neutral Fund with Quantitative and Fundamental Research

Devereaux, Alex
Alex Devereaux is a Portfolio Manager at Fidelity Management & Research Company — FMRCo — the investment adviser for Fidelity’s family of mutual funds. Fidelity Investments is a leading provider of investment management, retirement planning, portfolio guidance, brokerage, benefits outsourcing, and other financial products and services to more than 20 million individuals, institutions and financial intermediaries. In this role, Mr. Devereaux has been the Portfolio Manager of Fidelity Disciplined Equity Fund since January 2014. Prior to assuming his current responsibilities, Mr. Devereaux co-managed Fidelity Disciplined Equity Fund starting in January 2013. Previously, he was a quantitative analyst from 2005 to 2013. During this time, Mr. Devereaux’s responsibilities included alpha modeling, risk management and portfolio construction within the quantitative research group. Before joining Fidelity in 2005, Mr. Devereaux was a senior quantitative analyst at Evergreen Investments from 2004 to 2005, a quantitative analyst at Gartmore Global Investments from 2000 to 2004 and a consultant at FactSet Research Systems from 1998 to 2000. He has been in the investments industry since 1998. Mr. Devereaux earned his Bachelor of Business Administration degree from the University of Vermont and his Master of Science in finance degree from Boston College. Profile
TWST: Could you start by telling us a bit about the Disciplined Equity Fund and your investment strategy as it pertains to the fund?

Mr. Devereaux: The fund is a little bit unique

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the CEO: Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Interview with the CEO: BetterLife Pharma Inc. (OTCMKTS:BETRF)
Interview with the CEO: Cansortium Inc. (OTCMKTS:CNTMF)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
AI Opportunities Expand to Industrial, Utilities and Energy Sectors
India Fund Manager Expects Discretionary Spending to Grow
Inefficiency in Ex-US Markets Creates Opportunity to Buy at a Discount
ANALYST INTERVIEWS
Five Companies Dominate in Psychedelics-Based Drug Development
Cidara’s Long-Acting Antiviral Drug Could Be a Game Changer
Spotting Potential in the High-Risk, High Reward Neuroscience Space
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy